1. Home
  2. UCAR vs SYBX Comparison

UCAR vs SYBX Comparison

Compare UCAR & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UCAR
  • SYBX
  • Stock Information
  • Founded
  • UCAR 2013
  • SYBX N/A
  • Country
  • UCAR China
  • SYBX United States
  • Employees
  • UCAR N/A
  • SYBX N/A
  • Industry
  • UCAR Retail-Auto Dealers and Gas Stations
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UCAR Consumer Discretionary
  • SYBX Health Care
  • Exchange
  • UCAR Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • UCAR 13.3M
  • SYBX 13.6M
  • IPO Year
  • UCAR 2023
  • SYBX N/A
  • Fundamental
  • Price
  • UCAR $3.94
  • SYBX $1.32
  • Analyst Decision
  • UCAR
  • SYBX
  • Analyst Count
  • UCAR 0
  • SYBX 0
  • Target Price
  • UCAR N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • UCAR 105.4K
  • SYBX 22.4K
  • Earning Date
  • UCAR 07-22-2025
  • SYBX 08-07-2025
  • Dividend Yield
  • UCAR N/A
  • SYBX N/A
  • EPS Growth
  • UCAR N/A
  • SYBX N/A
  • EPS
  • UCAR N/A
  • SYBX 0.21
  • Revenue
  • UCAR $6,067,871.00
  • SYBX N/A
  • Revenue This Year
  • UCAR N/A
  • SYBX N/A
  • Revenue Next Year
  • UCAR N/A
  • SYBX N/A
  • P/E Ratio
  • UCAR N/A
  • SYBX $5.92
  • Revenue Growth
  • UCAR 124.09
  • SYBX N/A
  • 52 Week Low
  • UCAR $2.30
  • SYBX $0.90
  • 52 Week High
  • UCAR $9.43
  • SYBX $1.88
  • Technical
  • Relative Strength Index (RSI)
  • UCAR 54.16
  • SYBX 62.56
  • Support Level
  • UCAR $3.58
  • SYBX $1.19
  • Resistance Level
  • UCAR $3.99
  • SYBX $1.27
  • Average True Range (ATR)
  • UCAR 0.51
  • SYBX 0.08
  • MACD
  • UCAR -0.05
  • SYBX 0.01
  • Stochastic Oscillator
  • UCAR 38.10
  • SYBX 33.33

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: